WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy - 2000 - 2003
(2000; 81 pages) [French] Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentAbbreviations, Acronyms & WHO Regions
Afficher le documentHighlights - WHO Medicines Strategy: 2000 - 2003
Ouvrir ce répertoire et afficher son contenu1. The Impact of Essential Drugs
Ouvrir ce répertoire et afficher son contenu2. Strategic Directions
Afficher le document3. Core Functions Improving Health Through Knowledge, Advocacy and Partnership
Ouvrir ce répertoire et afficher son contenu4. Country Work - Why and How?
Ouvrir ce répertoire et afficher son contenu5. Framework for Action: Objectives and Expected Outcomes for 2000 - 2003
Fermer ce répertoire6. Monitoring Progress
Afficher le document6.1 Monitoring, evaluation and indicators
Afficher le document6.2 Country progress indicators for the WHO Medicines Strategy
Afficher le document6.3 Indicator values for the WHO Medicines Strategy
Afficher le document6.4 Improving the monitoring/evaluation process and tools
Afficher le documentReferences and Notes
 

6. Monitoring Progress

“Monitoring is an integral part of day-to-day management in successful drug programs. Systematic monitoring, based on program objectives and linked to specific activities, is essential for improving program performance and achieving long-term program goals.”

Management Sciences for Health/World Health Organization, 1997. 50

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012